September 1, 2022
FDA: Class I recall of Hamilton-C6 Intensive Care Ventilator
Editor's Note
The Food and Drug Administration (FDA) on August 29 identified the recall by Hamilton Medical AG of its Hamilton-C6 Intensive Care Ventilator as Class I, the most serious.
The recall was initiated because of potential water ingress between the indicator board and the ventilator’s main board that may cause breathing support to stop.
To date, there have been 128 complaints (worldwide), no injuries, and no deaths associated with this issue.
Distribution dates were August31, 2017, to May 20, 2022.
Free Daily News
- FBI investigates as Oracle health data breach exposes patient information
- Study: Pulse oximeters may misestimate oxygen saturation in darker skin tones
- FDA issues Class 1 recall for vascular cannulas
- Renewed push for healthcare price transparency faces familiar challenges
- Survey: Tariffs expected to increase hospital costs, disrupt supply chains
- Study: Arthroplasty implants linked to metal accumulation in cerebrospinal fluid
- Novel noninvasive surgical approach shows promise in treating severe OCD
- Study: Preop mental health assessment improves postop outcomes for older patients
- Study: Adenotonsillectomy reduces healthcare use in children with mild sleep-disordered breathing
- Introducing New Leader Toolkit: Your guide to OR leadership success
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement